Infectious diseases of the head and neck: A review

American Journal of Clinical Pathology

Volumn 128, Issue 1, 2007, Pages 35-67

  Montone, Kathleen T ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bacteria; Fungus; Head and neck; Infectious diseases; Protozoa; Virus

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT;

ABSCESS; ACTINOMYCOSIS; ALLERGIC GLOMERULONEPHRITIS; ANTHRAX; ASPERGILLUS FLAVUS; ASPIRATION BIOPSY; BACILLUS ANTHRACIS; BACTERIAL COLONIZATION; BARTONELLA HENSELAE; BURKITT LYMPHOMA; CAT SCRATCH DISEASE; CELL ASSAY; CELL CULTURE; CELL PROLIFERATION; CELLULITIS; CERVICAL LYMPHADENOPATHY; CHRONIC SINUSITIS; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; ENZYME ASSAY; EPSTEIN BARR VIRUS; GONORRHEA; HAEMOPHILUS INFLUENZAE TYPE A; HEAD AND NECK INFECTION; HEMANGIOMATOSIS; HERPES VIRUS; HERPES VIRUS INFECTION; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; INFECTIOUS MONONUCLEOSIS; KAPOSI SARCOMA; KLEBSIELLA RHINOSCLEROMATIS; LEISHMANIASIS; LEPROSY; LEUKOPLAKIA; LYMPHADENITIS; LYMPHOGRANULOMA VENEREUM; LYMPHOPROLIFERATIVE DISEASE; MOLLUSCUM CONTAGIOSUM; MORAXELLA CATARRHALIS; MOUTH ULCER; MYCOBACTERIOSIS; MYCOSIS; NASOPHARYNX CARCINOMA; PAROTID ENLARGEMENT; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROGNOSIS; PROTOZOAL INFECTION; PSEUDOMONAS; REVIEW; RHEUMATIC FEVER; RHINOSCLEROMA; RHINOSPORIDIOSIS; RHINOSPORIDIUM; SCARLET FEVER; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS; STOMATITIS; STREPTOCOCCUS PNEUMONIA; SURGICAL DRAINAGE; SYPHILIS; TONSILLITIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT DURATION; VASCULITIS; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; BACTERIAL INFECTION; HEAD; NECK; PATHOLOGY;

BACTERIAL INFECTIONS; HEAD; HUMANS; MYCOSES; NECK; PROTOZOAN INFECTIONS; VIRUS DISEASES;

EID: 34547096499     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/6BBT12WGNK77N4EH     Document Type: Review

References (268)

1. Brook I. Chronic sinusitis in children and adults: role of bacteria and antimicrobial management. Curr Allergy Asthma Rep. 2005;5:482-490.
2. Biel MA, Brown CA, Levinson RM. Evaluation of the microbiology of chronic maxillary sinusitis. Ann Otol Rhinol Laryngol. 1998;107(11 pt 1):942-945.
3. Brook I. Microbiology and management of sinusitis. J Otolaryngol. 1996;25:249-256.
4. Johnson JT, Ferguson BJ. Infection/paranasal sinus. Otolaryngol Head Neck Surg. 1998;2:1107-1134.
5. Wright ED, Frenkiel S. Infectious adult rhinosinusitis: etiology, diagnosis and management principles. J Otolaryngol. 2005;34(suppl):S7- S13.
6. Coleman H, Meer S, Altini M, et al. Maxillary sinus pathology in 119 patients: a histopathologic study. SADJ. 2005;60:140, 142-145.
7. Kennedy DW, Senior BA, Gannon FH, et al. Histology and histomorphometry of ethmoid bone in chronic rhinosinusitis. Laryngoscope. 1998;108(4pt 1):502-507.
8. Khalid AN, Hunt JL, Perloff JR, et al. The role of bone in chronic rhinosinusitis. Laryngoscope. 2002;112:1951-1957.
9. Perloff JR, Gannon FH, Bolger WE, et al. Bone involvement in sinusitis: an apparent pathway for the spread of disease. Laryngoscope. 2000;110:2095-2099.
10. Ebenfelt A. Bacterial location in chronic sinusitis. Am J Rhinol. 2005;19:458-461.
11. DelGaudio JM. Direct nasopharyngeal reflux of gastric acid is a contributing factor in refractory chronic rhinosinusitis. Laryngoscope. 2005;115:946-957.
12. Perloff JR, Palmer JN. Evidence of bacterial biofilms in a rabbit model of sinusitis. Am J Rhinol. 2005;19:1-6.
13. Sanderson AR, Leid JG, Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope. 2006;116:1121-1126.
14. Tewfik TL, Al Garni M. Tonsillopharyngitis: clinical highlights. J Otolaryngol. 2005;34(suppl 1):S45-S49.
15. Dell'Aringa AR, Juares AJ, Melo C, et al. Histological analysis of tonsillectomy and adenoidectomy specimens: January 2001 to May 2003. Rev Bras Otorrinolaringol (Engl Ed). 2005;71:18-22.
16. Dost P. Histological examination following adenoidectomy and tonsillectomy in children: surprising results are very rare. HNO. 2006;54:16-19.
17. Cockerell CJ, Connor DH. Cat scratch disease. In: Connor DH, Chandler FW, Schwartz DA, et al, eds. Pathology of Infectious Diseases. Stamford, CT: Appleton and Lange; 1997:461-468.
18. Murakami K, Tsukahara M, Tsuneoka H, et al. Cat scratch disease: analysis of 130 seropositive cases. J Infect Chemother. 2002;8:349-352.
19. Adal KA, Cockerell CJ, Petri WA Jr. Cat scratch disease, bacillary angiomatosis, and other infections due to Rochalimaea. N Engl J Med. 1994;330:1509-1515.
20. English CK, Wear DJ, Margileth AM. Cat-scratch disease: isolation and culture of the bacterial agent. JAMA. 1988;259:1347-1352.
21. Min KW, Reed JA, Welch DF, et al. Morphologically variable bacilli of cat scratch disease are identified by immunocytochemical labeling with antibodies to Rochalimaea henselae. Am J Clin Pathol. 1994;101:607-610.
22. Chian CA, Arrese JE, Pierard GE. Skin manifestations of Bartonella infections. Int J Dermatol. 2002;41:461-466.
23. de Kort JG, Robben SG, Schrander JJ, et al. Multifocal osteomyelitis in a child: a rare manifestation of cat scratch disease: a case report and systematic review of the literature. J Pediatr Orthop B. 2006;15:285-288.
24. Rolain JM, Gouriet F, Enea M, et al. Detection by immunofluorescence assay of Bartonella henselae in lymph nodes from patients with cat scratch disease. Clin Diagn Lab Immunol. 2003;10:686-691.
25. Qian X, Jin L, Hayden RT, et al. Diagnosis of cat scratch disease with Bartonella henselae infection in formalin-fixed paraffin-embedded tissues by two different PCR assays. Diagn Mol Pathol. 2005;14:146-151.
26. Hansmann Y, DeMartino S, Piemont Y, et al. Diagnosis of cat scratch disease with detection of Bartonella henselae by PCR: a study of patients with lymph node enlargement. J Clin Microbiol. 2005;43:3800-3806.
27. Maruyama S, Kabeya H, Nogami S, et al. Three cases of cat scratch disease diagnosed by indirect immunofluorescence antibody assay and/or polymerase chain reaction of 16S rRNA gene of Bartonella henselae. J Vet Med Sci. 2000;62:1321-1324.
28. Cheuk W, Chan AK, Wong MC, et al. Confirmation of diagnosis of cat scratch disease by immunohistochemistry. Am J Surg Pathol. 2006;30:274-275.
29. Bonatti H, Mendez J, Guerrero I, et al. Disseminated Bartonella infection following liver transplantation. Transpl Int. 2006;19:683-687.
30. Rigopoulos D, Paparizos V, Katsambas A. Cutaneous markers of HIV infection. Clin Dermatol. 2004;22:487-498.
31. Ahsan N, Holman MJ, Riley TR, et al. Peliosis hepatis due to Bartonella henselae in transplantation: a hemato-hepato-renal syndrome. Transplantation. 1998;65:1000-1003.
32. Kreitzer T, Saoud A. Bacillary angiomatosis following the use of long-term methotrexate therapy: a case report. W V Med J. 2006;102:317-318.
33. Turgut M, Alabaz D, Karakas M, et al. Bacillary angiomatosis in an immunocompetent child with a grafted traumatic wound. J Dermatol. 2004;31:844-847.
34. LeBoit PE. Bacillary angiomatosis. In: Connor DH, Chandler FW, Schwartz DA, et al, eds. Pathology of Infectious Diseases. Stamford, CT: Appleton and Lange; 1997:407-415.
35. Amsbaugh S, Huiras E, Wang NS, et al. Bacillary angiomatosis associated with pseudoepitheliomatous hyperplasia. Am J Dermatopathol. 2006;28:32-35.
36. Dauga C, Miras I, Grimont PA. Identification of Bartonella henselae and B quintana 16s rDNA sequences by branch-, genus- and species-specific amplification. J Med Microbiol. 1996;45:192-199.
37. Reed JA, Brigati DJ, Flynn SD, et al. Immunocytochemical identification of Rochalimaea henselae in bacillary (epithelioid) angiomatosis, parenchymal bacillary peliosis, and persistent fever with bacteremia. Am J Surg Pathol. 1992;16:650-657.
38. Sander A, Penno S. Semiquantitative species-specific detection of Bartonella henselae and Bartonella quintana by PCR-enzyme immunoassay. J Clin Microbiol. 1999;37:3097-3101.
39. Manolidis S, Frenkiel S, Yoskovitch A, et al. Mycobacterial infections of the head and neck. Otolaryngol Head Neck Surg. 1993;109(3 pt 1):427-433.
40. Bayazit YA, Bayazit N, Namiduru M. Mycobacterial cervical lymphadenitis. ORL J Otorhinolaryngol Relat Spec. 2004;66:275-280.
41. Albright JT, Pransky SM. Non-tuberculous mycobacterial infections of the head and neck. Pediatr Clin North Am. 2003;50:503-514.
42. Aljafari AS, Khalil EA, Elsiddig KE, et al. Diagnosis of tuberculous lymphadenitis by FNAC, microbiological methods and PCR: a comparative study. Cytopathology. 2004;15:44-48.
43. Goel MM, Ranjan V, Dhole TN, et al. Polymerase chain reaction vs conventional diagnosis in fine needle aspirates of tuberculous lymph nodes. Acta Cytol. 2001;45:333-340.
44. Baek CH, Kim SI, Ko YH, et al. Polymerase chain reaction detection of Mycobacterium tuberculosis from fine-needle aspirate for the diagnosis of cervical tuberculous lymphadenitis. Laryngoscope. 2000;110:30-34.
45. Yokoyama J, Shiga K, Saijo S, et al. Rapid diagnosis of cervical tuberculous lymphadenitis by application of DNA probe. Otolaryngol Head Neck Surg. 1999;121:501-504.
46. Pahwa R, Hedau S, Jain S, et al. Assessment of possible tuberculous lymphadenopathy by PCR compared to non-molecular methods. J Med Microbiol. 2005;54:873-878.
47. Kwon KS, Oh CK, Jang HS, et al. Detection of mycobacterial DNA in cervical granulomatous lymphadenopathy from formalin-fixed, paraffin-embedded tissue by PCR. J Dermatol. 2000;27:355-360.
48. Kraus M, Benharroch D, Kaplan D, et al. Mycobacterial cervical lymphadenitis: the histological features of non-tuberculous mycobacterial infection. Histopathology. 1999;35:534-538.
49. Ramanathan VD, Jawahar MS, Paramasivan CN, et al. A histological spectrum of host responses in tuberculous lymphadenitis. Indian J Med Res. 1999;109:212-220.
50. Brady JG, Schutze GE, Seibert R, et al. Detection of mycobacterial infections using the Dieterle stain. Pediatr Dev Pathol. 1998;1:309-313.
51. Thompson LD. Rhinoscleroma. Ear Nose Throat J. 2002;81:506.
52. Schwartz DA, Geyer SJ. Klebsiella and rhinoscleroma. In: Connor DH, Chandler FW, Schwartz DA, et al, eds. Pathology of Infectious Diseases. Stamford, CT: Appleton and Lange; 1997:589-595.
53. Bhargava D, Date A. Palatal presentation of scleroma. J Laryngol Otol. 2001;115:679-680.
54. Alfar-Monge JM, Fernandez-Espinosa J, Soda-Merhy A. Scleroma of the lower respiratory tract: case report and review of the literature. J Laryngol Otol. 1994;108:161-163.
55. Iyengar P, Laughlin S, Keshavjee S, et al. Rhinoscleroma of the larynx [letter]. Histopathology. 2005;47:224-225.
56. De Champs C, Vellin JF, Diancourt L, et al. Laryngeal scleroma associated with Klebsiella pneumoniae subsp ozaenae. J Clin Microbiol. 2005;43:5811-5813.
57. Verma G, Kanawaty D, Hyland R. Rhinoscleroma causing upper airway obstruction. Can Respir J. 2005;12:43-45.
58. Ammar ME, Rosen A. Rhinoscleroma mimicking nasal polyposis. Ann Otol Rhinol Laryngol. 2001;110:290-292.
59. Kasper HU, Hegenbarth V, Buhtz P. Rhinoscleroma associated with Rosai-Dorfman reaction of regional lymph nodes. Pathol Int. 2004;54:101-104.
60. Gumprecht TF, Nichols PW, Meyer PR. Identification of rhinoscleroma by immunoperoxidase technique. Laryngoscope. 1983;93:627-629.
61. Meyer PR, Shum TK, Becker TS, et al. Scleroma (rhinoscleroma): a histologic immunohistochemical study with bacteriologic correlates. Arch Pathol Lab Med. 1983;107:377-383.
62. Cockerell CJ. Leprosy. In: Connor DH, Chandler FW, Schwartz DA, et al, eds. Pathology of Infectious Diseases. Stamford, CT: Appleton and Lange; 1997:605-614.
63. Jacobson RR, Krahenbuhl JL. Leprosy. Lancet. 1999;353:655-656.
64. Martins AC, Castro Jde C, Moreira JS. A ten-year historic study of paranasal cavity endoscopy in patients with leprosy. Rev Bras Otorhinolaryngol (Engl Ed). 2005;71:609-615.
65. Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five-group system. Int J Lepr Other Mycobact Dis. 1966;34:255-273.
66. Moschella SL. An update on the diagnosis and treatment of leprosy. J Am Acad Dermatol. 2004;51:417-426.
67. Katoch VM. Advances in the diagnosis and treatment of leprosy. Expert Rev Mol Med. 2002;2002:1-14.
68. Scollard DM, Gillis TP, Williams DL. Polymerase chain reaction assay for the detection and identification of Mycobacterium leprae in patients in the United States. Am J Clin Pathol. 1998;109:642-646.
69. Natrajan M, Katoch K, Katoch VM, et al. In situ hybridization in the histological diagnosis of early and clinically suspect leprosy. Int J Lepr Other Mycobact Dis. 2004;72:296-305.
70. Arnoldi J, Schluter C, Duchrow M, et al. Species-specific assessment of Mycobacterium leprae in skin biopsies by in situ hybridization and polymerase chain reaction. Lab Invest. 1992;66:618-623.
71. Balmelli C, Gunthard HF. Gonococcal tonsillar infection: a case report and literature review. Infection. 2003;31:362-365.
72. Tikjob G, Petersen CS, Ousted M, et al. Localization of gonococci in the anterior oral cavity: a possible reservoir of the gonococcal infection? Ann Clin Res. 1985;17:73-75.
73. Koelker SE, Manz HJ, Schwartz DA. Syphilis. In: Connor DH, Chandler FW, Schwartz DA, et al, eds. Pathology of Infectious Diseases. Stamford, CT: Appleton and Lange; 1997:605-614.
74. Little JW Syphilis: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:3-9.
75. Bruce AJ, Rogers RS III. Oral manifestations of sexually transmitted diseases. Clin Dermatol. 2004;22:520-527.
76. Zawar V, Chuh A, Gugle A. Oral lesions of syphilis: an isolated, rare manifestation [serial online]. Dermatol Online J. 2005;11:46. Available at http://dermatology.cdib.Org/113/unknown/Zawar.html. Accessed May 13, 2007.
77. Barrett AW, Dorrego MV, Todgson TA, et al. The histopathology of syphilis of the oral mucosa. J Oral Pathol Med. 2004;3:286-291.
78. Lu SY, Eng HL. Secondary syphilis-related oral ulcers: report of four cases. Chang Gung Med J. 2002;25:683-688.
79. Miller M, Haddad AJ. Cervicofacial actinomycosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:496-508.
80. Pulverer G, Schutt-Gerowitt H, Schaal KP. Human cervicofacial actinomycoses: microbiological data for 1997 cases. Clin Infect Dis. 2003;37:490-497.
81. Smego RA Jr, Foglia G. Actinomycosis. Clin Infect Dis. 1998;26:1255-1261.
82. Volante M, Contucci AM, Fantoni M, et al. Cervicofacial actinomycosis: still a difficult differential diagnosis. Acta Otorhinolaryngol Ital. 2005;25:116-119.
83. Stewart AE, Palma JR, Amsberry JK. Cervicofacial actinomycosis. Otolaryngol Head Neck Surg. 2005;132:957-959.
84. Oostman O, Smego RA. Cervicofacial actinomycosis: diagnosis and management. Curr Infect Dis Rep. 2005;7:170-174.
85. Belmont MJ, Behar PM, Wax MK. Atypical presentations of actinomycosis. Head Neck. 1999;21:264-268.
86. Park YH, Baik JH, Yoo J. Acute thyroiditis of actinomycosis. Thyroid. 2005;15:1395-1396.
87. Subha ST, Raman R, Cheah PL, et al. Actinomyces infection of the mastoid: a rare entity. Med J Malaysia. 2004;59:680-681.
88. Ulvi BM. Actinomycosis of the parotid gland. Plost Reconsfr Surg. 2005;115:659-661.
89. Ozcan C, Talas D, Gorur K, et al. Actinomycosis of the middle turbinate: an unusual cause of nasal obstruction. Eur Arch Otorhinolaryngol. 2005;262:412-415.
90. Bubbico L, Caratozzolo M, Nardi F, et al. Actinomycosis of submandibular gland: an unusual presentation. Acta Otorhinolaryngol Ital. 2004;24:37-39.
91. Cevera JJ, Butehorn HF III, Shapiro J, et al. Actinomycosis abscess of the thyroid gland. Laryngoscope. 2003;113:2108-2111.
92. Roth M, Montone KT. Actinomycosis of the paranasal sinuses: a case report and review. Otolaryngol Head Neck Surg. 1996;114:818-821.
93. Jaax NK, Fritz DL. Anthrax. In: Connor DH, Chandler FW, Schwartz DA, et al, eds. Pathology of Infectious Diseases, Stamford, CT: Appleton and Lange; 1997:397-406.
94. Ezzell JW, Abshire TG, Little SF, et al. Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N- acetylglucosamine polysaccharide. J Clin Microbiol. 1990;28:223-231.
95. Brandwein M. Histopathology of sinonasal fungal disease. Otolaryngol Clin North Am. 1993;26:949-978.
96. Corey JP, Romberger CF, Shaw GY. Fungal disease of the sinuses. Otolaryngol Head Neck Surg. 1990;103:1012-1015.
97. Adelson RT, Marple BF. Fungal rhinosinusitis: state of the art diagnosis and treatment. J Otolaryngol. 2005;34(suppl 1):S18-S23.
98. Granville L, Chirala M, Cernoch P, et al. Fungal sinusitis: histologic spectrum and correlation with culture. Hum Pathol. 2004;35:474-481.
99. Taxy JB. Paranasal fungal sinusitis: contributions of histopathology to diagnosis: a report of 60 cases and literature review. Am J Surg Pathol. 2006;30:713-720.
100. Ferreiro JA, Carlson BA, Cody DT III. Paranasal sinus fungus balls. Head Neck. 1997;19:481-486.
101. Dufour X, Kauffmann-Lacroix C, Ferrie JC, et al. Paranasal sinus fungus ball: epidemiology, clinical features and diagnosis: a retrospective analysis of 173 cases from a single medical center in France, 1989-2002. Med Mycol. 2006;44:61-67.
102. Dufour X, Kauffmann-Lacroix C, Ferrie JC, et al. Paranasal sinus fungus ball and surgery: a review of 175 cases. Rhinology. 2005;43:34-39.
103. Gungor A, Adusumilli V, Corey JP. Fungal sinusitis: progression of disease in immunosuppression: a case report. Ear Nose Throat J. 1998;77:207-210.
104. Katzenstein AL, Sale SR, Greenberger PA. Pathologic findings in allergic Aspergillus sinusitis: a newly recognized form of sinusitis. Am J Surg Pathol. 1983;7:439-443.
105. Allphin AL, Strauss M, Abdul-Karim FW. Allergic fungal sinusitis: problems in diagnosis and treatment. Laryngoscope. 1991;101:815-820.
106. Bent JP, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111:580-587.
107. Cody DT, Neel HB, Ferreiro JA, et al. Allergic fungal sinusitis: the Mayo Clinic experience. Laryngoscope. 1994;104:1074-1079.
108. Corey JP. Allergic fungal sinusitis. Otolaryngol Clin North Am. 1992;25:225-229.
109. Ence BK, Gourley DS, Jorgensen NL, et al. Allergic fungal sinusitis. Am J Rhinol. 1990;4:169-178.
110. Goldstein MF. Allergic fungal sinusitis: an under diagnosed problem. Hosp Pract (Off Ed). 1992:73-74, 79-84, 87-88, passim.
111. Schubert MS. Allergic fungal sinusitis. Clin Rev Allergy Immunol. 2006;30:205-216.
112. Bartynski JM, McCaffrey TV, Frigas E. Allergic fungal sinusitis secondary to dematiaceous fungi: Curvularia lunata and Alternaria. Otolaryngol Head Neck Surg. 1990;103:32-39.
113. Friedman GC, Hartwick RW, Ro JY, et al. Allergic fungal sinusitis report of three cases associated with dematiaceous fungi. Am J Clin Pathol. 1991;96:368-372.
114. Manning SC, Schaefer SD, Close LG, et al. Culture-positive allergic fungal sinusitis. Arch Otolaryngol Head Neck Surg. 1991;117:174-178.
115. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999;74:877-884.
116. Heffner DK. Allergic fungal sinusitis is a histopathologic diagnosis; paranasal mucocele is not. Ann Diagn Pathol. 2004;8:316-323.
117. Campbell JM, Graham M, Gray HC, et al. Allergic fungal sinusitis in children. Ann Allergy Asthma Immunol. 2006;96:286-290.
118. Singh N, Bhalodiya NH. Allergic fungal sinusitis (AFS): earlier diagnosis and management. J Laryngol Otol. 2005;119:875-881.
119. Manning SC, Mabry RL, Schaefer SD, et al. Evidence of IgE-mediated hypersensitivity in allergic fungal sinusitis. Laryngoscope. 1993;103:717-721.
120. Ramadan HH, Quraishi HA. Allergic mucin without fungus. Am J Rhinol. 1997;11:145-147.
121. Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope. 2000;110(5 pt 1):799-813.
122. Shatkin JS, Delsupehe KG, Thisted RA, et al. Mucosal allergy in the absence of systemic allergy in nasal polyposis and rhinitis: a meta-analysis. Otolaryngol Head Neck Surg. 1994;111:553-556.
123. Perez LA, Lanza DC, Loevner LA, et al. In situ hybridization for Aspergillus and Penicillium in allergic fungal sinusitis: a rapid means of speciating fungal pathogens in tissues. Laryngoscope. 1997;107:233-240.
124. 124- Smith KJ, Yeager J, Skelton H. Molluscum contagiosum: its clinical, histopathologic, and immunohistochemical spectrum. Int J Dermatol. 1999;38:664-672.
125. Dohil MA, Lin P, Lee J, et al. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol. 2006;54:47-54.
126. Redmond RM. Molluscum contagiosum is not always benign [letter]. BMJ. 2004;329:403.
127. Pitini V, Arrigo C, Barresi G. Disseminated molluscum contagiosum in a patient with chronic lymphocytic leukaemia after alemtuzumab. Br J Haematol. 2003;123:565.
128. Dave S, Thappa DM, Karthikeyan K. Disseminated and disfiguring molluscum contagiosum in a child. Pediatr Dermatol. 2003;20:436-439.
129. Forghani B, Oshiro LS, Chan CS, et al. Direct detection of molluscum contagiosum virus in clinical specimens by in situ hybridization using biotinylated probe. Mol Cell Probes. 1992;6:67-77.
130. Chidzonga MM. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial clinics. Oral Dis. 2003;9:317-322.
131. Campanini A, Marani M, Mastroianni A, et al. Human immunodeficiency virus infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies. Acta Otorhinolaryngol Ital. 2005;25:30-35.
132. Hillel A, O'Mara W, Nemechek A, et al. Head and neck manifestations in HIV infection. J La State Med Soc. 2004;156:245-253.
133. Ndjolo A, Njock R, Ngowe NM, et al. Early ENT manifestations of HIV infection/AIDS: an analysis of 76 cases observed in Africa [in French]. Rev Laryngol Otol Rhinol (Bord). 2004;125:39-43.
134. Marsot-Dupuch K, Quillard J, Meyohas MC. Head and neck lesions in the immunocompromised host. Eur Radiol. 2004;14(suppl 3):E155-E167.
135. Gurney TA, Murr AH. Otolaryngologic manifestations of human immunodeficiency virus infection. Otolaryngol Clin North Am. 2003;36:607-624.
136. Reznik DA. Oral manifestations of HIV disease. Top HIV Med. 2005-2006;13:143-148.
137. Baroni CD, Uccini S. The lymphadenopathy of HIV infection. Am J Clin Pathol. 1993;99:397-401.
138. Burke AP, Anderson D, Mannan P, et al. Systemic lymphadenopathic histology in human immunodeficiency virus-1-seropositive drug addicts without apparent acquired immunodeficiency syndrome. Hum Pathol. 1994;25:248-256.
139. Ost A, Baroni CD, Biberfeld P, et al. Lymphadenopathy in HIV infection: histological classification and staging. Acta Pathol Microbiol Immunol Scand Suppl. 1989;8:7-15.
140. Favia G, Capodiferro S, Scivetti M, et al. Multiple parotid lymphoepithelial cysts in patients with HIV-infection: report of two cases. Oral Dis. 2004;10:151-154.
141. Ihrler S, Zietz C, Riederer A, et al. HIV-related parotid lymphoepithelial cysts: immunohistochemistry and 3-D reconstruction of surgical and autopsy material with special reference to formal pathogenesis. Virchows Arch. 1996;429:139-147.
142. Mandel L, Reich R. HIV parotid gland lymphoepithelial cysts: review and case reports. Oral Surg Ord Med Oral Pathol. 1992;74:273-278.
143. Wilkins K, Turner R, Doley JC, et al. Cutaneous malignancy and human immunodeficiency vims disease. J Am Acad Dermatol. 2006;54:189-206.
144. 144- Raju PV, Rao GR, Ramani TV, et al. Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection. Int J Dermatol. 2005;44:646-649.
145. Arduino PG, Porter SR. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Oral Dis. 2006;12:254-270.
146. Kolokotronis A, Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect. 2006;12:202-211.
147. Stoopler ET. Oral herpetic infections (HSV 1-8). Dent Clin North Am. 2005;49:15-29.
148. Huber MA. Herpes simplex type-1 virus infection. Quintessence Int. 2003;34:453-467.
149. Simmons A. Clinical manifestations and treatment considerations of herpes simplex virus infection. J Infect Dis. 2002;186(suppl 1):S71-S77.
150. Pepose JS, Keadle TL, Morrison LA. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol. 2006;141:547-557.
151. Bonfioli AA, Eller AW. Acute retinal necrosis. Semin Ophthalmol. 2005;20:155-160.
152. Syrjänen S, Leimola-Virtanen R, Schmidt-Westhausen A, et al. Oral ulcers in AIDS patients frequently associated with cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections. J Oral Pathol Med. 1999;28:204-209.
153. Leimola-Virtanen R, Happonen RP, Syrjanen S. Cytomegalovirus (CMV) and Helicobacter pylori (HP) found in oral mucosal ulcers. J Oral Pathol Med. 1995;24:14-17.
154. Chan BW, Woo JK, Liew CT. Cytomegalovirus infection of the nasopharynx. J Clin Pathol. 2002;55:970-972.
155. Wiegand TW, Young LH. Cytomegalovirus retinitis. Int Ophthalmol Clin. 2006;46:91-110.
156. Scholz M, Doerr HW, Cinatl J. Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol. 2003;11:171-178.
157. See RF, Rao NA. Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy. Ophthalmol Clin North Am. 2002;15:529-536.
158. Lopez-Amado M, Yebra-Pimentel MT, Garcia-Sarandeses A. Cytomegalovirus causing necrotizing laryngitis in a renal and cardiac transplant recipient. Head Neck. 1996;18:455-457.
159. Wax TD, Layfield LJ, Zaleski S, et al. Cytomegalovirus sialadenitis in patients with the acquired immunodeficiency syndrome: a potential diagnostic pitfall with fine-needle aspiration cytology. Diagn Cytopathol. 1994;10:169-172.
160. Frank TS, LiVolsi VA, Connor AM. Cytomegalovirus infection of the thyroid in immunocompromised adults. Yale J Biol Med. 1987;60:1-8.
161. Liesegang TJ. Herpes zoster virus infection. Curr Opin Ophthalmol. 2004;15:531-536.
162. Gurwood AS, Savochka J, Sirgany BJ. Herpes zoster ophthalmicus. Optometry. 2002;73:295-302.
163. Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 2004;70:1279-1287.
164. 164- Cohen JI. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases. Semin Hematol. 2003;40:116-123.
165. Godshall SE, Kirchner JT. Infectious mononucleosis: complexities of a common syndrome. Postgrad Med. 2000;107:175-179,183-184.
166. Gowing NF. Infectious mononucleosis: histopathologic aspects. Pathol Annu. 1975;10:1-20.
167. Sengor A, Willke A, Aydin O, et al. Isolated necrotizing epiglottitis: report of a case in a neutropenic patient and review of the literature. Ann Otol Rhinol Laryngol. 2004; 113(3 pt 1):225-228.
168. Iijima T, Sumazaki R, Mori N, et al. A pathological and immunohistological case report of fatal infectious mononucleosis, Epstein-Barr vims infection, demonstrated by in situ and Southern blot hybridization. Virchows Arch A Pathol Anat Histopathol. 1992;421:73-78.
169. Moura MD, Grossmann Sde M, Fonseca LM, et al. Risk factors for oral hairy leukoplakia in HIV-infected adults of Brazil. J Oral Pathol Med. 2006;35:321-326.
170. Syrjänen S, Laine P, Happonen R-P, et al. Oral hairy leukoplakia is not a specific sign of HIV-infection but related to immunosuppression in general. J Oral Pathol Med. 1989;18:28-31.
171. Eisenberg E, Krutchkoff D, Yamase H. Incidental oral hairy leukoplakia in immunocompetent persons: a report of two cases. Oral Surg Oral Med Oral Pathol. 1992;74:332-333.
172. Felix DH, Watret K, Wray D, et al. Hairy leukoplakia in an-HlV-negative, nonimmunosuppressed patient. Oral Surg Oral Med Oral Pathol. 1992;74:563-566.
173. Triantos D, Porter SR, Scully C, et al. Oral hairy leukoplakia: clinicopathologic features, pathogenesis, diagnosis, and clinical significance. Clin Infect Dis. 1997;25:1392-1396.
174. Greenspan JS, Greenspan D, Lennette ET, et al. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia: an AIDS-associated lesion. New Engl J Med. 1985;313:1564-1571.
175. Dias EP, Rocha ML, Silva A Jr, et al. Oral hairy leukoplakia: histopathologic and cytopathologic features of a subclinical phase. Am J Clin Pathol. 2000;114:395-401.
176. Frizzera G, Hanto DW, Gajl-Peczalska K, et al. Polymorphic diffuse B cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res. 1981;41:4262-4279.
177. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res. 1981;41:4253-4261.
178. Hanto DW, Gajl-Peczalska K, Frizzera G, et al. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative disease occurring after renal transplantation: clinical, pathologic, and virologic findings and implications for therapy. Ann Surg. 1983;198:356-369.
179. Nalesnik M, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988;133:173-193.
180. Purtilo DT, Strobach RS, Okanao M, et al. Epstein-Barr vims-associated lymphoproliferative disorders. Lab Invest. 1992;67:5-23.
181. Purtilo DT. Opportunistic cancers in patients with immunodeficiency syndromes. Arch Pathol Lab Med. 1987;111:1123-1129.
182. Cohen JI. Epstein-Barr virus lymphoproliferative disease associated with acquired immune deficiency. Medicine. 1991;70:137-160.
183. Starzl TE, Porter KA, Iwatsuki S, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1988;1:583-587.
184. Hague K, Catalano P, Rothschild M, et al. Posttransplant lymphoproliferative disease presenting as sudden respiratory arrest in a three-year-old child. Ann Otol Rhinol Laryngol. 1997;106:244-247.
185. Lones MA, Mishalani S, Shintaku IP, et al. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring. Hum Pathol. 1995;26:525-530.
186. Harris NL, Swerdlow SH, Frizerra G, et al. Post-transplant lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:264-269. World Health Organization Classification of Tumours.
187. Ho M, Miller G, Atchison RW, et al. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis. 1985;152:876-886.
188. Randhawa PS, Jaffe R, Demetris AJ, et al. Expression of Epstein-Barr virus small RNA (by EBER-1 gene) in liver specimens from transplant recipients with post-transplantation disease. N Engl J Med. 1992;137:1710-1714.
189. Montone KT, Hodinka R, Salhany KE, et al. Identification of lytic Epstein-Barr vims activity in posttransplant lymphoproliferative disease. Mod Pathol. 1996;9:621-630.
190. Fischer A, Blanche S, Le Bidois J, et al. Anti-B cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med. 1991;324:1451-1456.
191. Porter DL, Orloff GJ, Antin JH. Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant. Transplant Sci. 1994;4:12-16.
192. Haque T, Amlot PL, Helling N, et al. Reconstitution of EBV-specific T-cell immunity in solid organ transplant recipients. J Immunol. 1998;160:6204-6209.
193. Gilmour KC, Gaspat HB. Pathogenesis and diagnosis of X-linked lymphoproliferative disease. Expert Rev Mol Diagn. 2003;3:549-561.
194. Caspar HB, Sharifi R, Gilmour KC, et al. X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective. Br J Haematol. 2002;119:585-595.
195. Morra M, Howie D, Grande MS, et al. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu Rev Immunol. 2001;19:657-682.
196. Nelson DL, Terhorst C. X-linked lymphoproliferative syndrome. Clin Exp Immunol. 2000;122:291-295.
197. Maia DM, Garwacki CP. X-linked lymphoproliferative disease: pathology and diagnosis. Pediatr Dev Pathol. 1999;2:72-77.
198. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004;10:803-821.
199. van den Bosch CA. Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol. 2004;5:738-746.
200. Fujita F, Buziba N, Kumatori A, et al. Early stage of Epstein-Barr vims lytic infection leading to the "starry sky" pattern formation in endemic Burkitt lymphoma. Arch Pathol Lab Med. 2004;128:549-552.
201. Labrecque LG, Xue SA, Kazembe P, et al. Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: correlation witht patient response to therapy. Int J Cancer. 1999;81:6-11.
202. Hummel M, Bentink S, Berger H, et al, for the Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419-2430.
203. Dave SS, Fu K, Wright GW, et al, for the Lymphoma/Leukemia Molecular Profiling Project. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med. 2006;354:2431-2442.
204. Vega F, Lin P, Medeiros LJ. Extranodal lymphomas of the head and neck. Ann Diagn Pathol. 2005;9:340-350.
205. Sheahan P, Donnelly M, O'Reilly S, et al. T/NK cell non-Hodgkin's lymphoma of the sinonasal tract. J Laryngol Otol. 2001;115:1032-1035.
206. Ohshima K, Suzumiya J, Shimazaki K, et al. Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage. Histopathology. 1997;31:444-450.
207. Medeiros LJ, Jaffe ES, Chen YY, et al. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol. 1992;16:439-447.
208. Hongyo T, Li T, Syaifudin M. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan. Cancer Res. 2000;60:2345-2347.
209. Ko YH, Choi KE, Han JH, et al. Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma. Cytometry. 2001;46:85-91.
210. Cho HI, Hong YS, Lee MA, et al. Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas. Int J Hematol. 2006;83:66-73.
211. Chan AT, Teo PM, Huang DP. Pathogenesis and treatment of nasopharyngeal carcinoma. Semin Oncol. 2004;6:794-801.
212. Dolcetti R, Menezes J. Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: new immunobiological and molecular insights on a long-standing etiopathogenic association. Adv Cancer Res. 2003;87:127-157.
213. Fan SQ, Ma J, Zhou J, et al. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol. 2006;37:593-605.
214. Biswal BM, Kareem A, Ahmed NM. Hypertrophic osteoarthropathy: an unusual manifestation in nasopharyngeal cancer. Australas Radiol. 2001;45:71-73.
215. Nakao K, Yuge T, Mochiki M, et al. Detection of Epstein-Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:338-340.
216. Nakao K, Mochiki M, Nibu K, et al. Analysis of prognostic factors of nasopharyngeal carcinoma: impact of in situ hybridization for Epstein-Barr virus encoded small RNA 1. Otolaryngol Head Neck Surg. 2006;134:639-645.
217. Zhong BL, Zong YS, Lin SX, et al. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma. Ai Zheng. 2006;25:136-142.
218. Pak MW, To KF, Lo YM, et al. Nasopharyngeal carcinoma in situ (NPCIS): pathologic and clinical perspectives. Head Neck. 2002;24:989-995.
219. Wong MM, Lye MS, Cheng HM, et al. Epstein-Barr virus serology in the diagnosis of nasopharyngeal carcinoma. Asian Pac J Allergy Immunol. 2005;23:65-67.
220. Zerr DM. Human herpesvirus 6: a clinical update. Herpes. 2006;13:20-24.
221. Ward KN. Human herpesviruses-6 and -7 infections. Curr Opin Infect Dis. 2005;18:247-252.
222. Clark DA. Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients. Int J Hematol. 2002;76(suppl 2):246-252.
223. Jackson MA, Sommerauer JF. Human herpesviruses 6 and 7. Pediatr Infect Dis J. 2002;21:565-566.
224. Chen T, Hudnall SD. Anatomical mapping of human herpesvirus reservoirs of infection. Mod Pathol. 2006;19:726-737.
225. Ablashi DV, Chatlynne LG, Whitman JE Jr, et al. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev. 2002;15:439-464.
226. Malnati MS, Dagna L, Ponzoni M, et al. Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies. Rev Clin Exp Hematol. 2003;7:375-405.
227. Aoki Y, Tosato G. Pathogenesis and manifestations of human herpesvirus-8-associated disorders. Semin Hematol. 2003;40:143-153.
228. Schwartz RA. Kaposi's sarcoma: an update. J Surg Oncol. 2004;87:146-151.
229. Vanni T, Sprinz E, Machado MW, et al. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives. Cancer Treat Rev. 2006;32:445-455.
230. Almadori G, Galli J, Cadoni G, et al. Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance. Head Neck. 2002;24:597-604.
231. Sisk EA, Soltys SG, Zhu S, et al. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck. 2002;24:841-849.
232. Baez A, Almodovar JI, Cantor A, et al. High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population. Head Neck. 2004;26:778-784.
233. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24:736-747.
234. Torrente MC, Ampuero S, Abud M, et al. Molecular detection and typing of human papillomavirus in laryngeal carcinoma specimens. Acta Otolaryngol. 2005;125:888-893.
235. Makannavar JH, Chavan SS. Rhinosporidiosis: a clinicopathological study of 34 cases. Indian J Pathol Microbiol. 2001;44:17-21.
236. Parthasarathi R, Sen S, Khan M. Conjunctival rhinosporidiosis: J Indian Med Assoc. 2003;101:667-670.
237. Khoo JJ, Kumar KS. Rhinosporidiosis presenting as recurrent nasal polyps. Med J Malaysia. 2003;58:282-285.
238. Fredricks DN, Jolley JA, Lepp PW, et al. Rhinosporidium seeberi: a human pathogen from a novel group of aquatic protistan parasites. Emerg Infect Dis. 2000;6:273-282.
239. Herr RA, Ajello L, Taylor JW, et al. Phylogenetic analysis of Rhinosporidium seeberi's 18S small-subunit ribosomal DNA groups this pathogen among members of the protoctistan Mesomycetozoa clade. J Clin Microbiol. 1999;37:2750-2754.
240. Mohanty RC, Khalkho J, Sahu A. Diagnosis of disseminated rhinosporidiosis by fine needle aspiration cytology [letter]. Acta Cytol. 2006;50:234.
241. Angunawela P, De Tissera A, Dissanaike AS. Rhinosporidiosis presenting with two soft tissue tumors followed by dissemination. Pathology. 1999;31:57-58.
242. Thappa DM, Venkatesan S, Sirka CS, et al. Disseminated cutaneous rhinosporidiosis. J Dermatol. 1998;25:527-532.
243. Kafetzis DA. An overview of paediatric leishmaniasis. J Postgrad Med. 2003;49:31-38.
244. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis. 1997;24:684-703.
245. Murray HW, Berman JD, Davies CR, et al. Advances in leishmaniasis. Lancet. 2005;366:1561-1577.
246. Markle WH, Makhoul K. Cutaneous leishmaniasis: recognition and treatment. Am Fam Physician. 2004;69:1455-1460.
247. Willard RJ, Jeffcoat AM, Benson PM, et al. Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options. J Am Acad Dermatol. 2005;52:977-987.
248. Weina PJ, Neafie RC, Wortmann G, et al. Old world leishmaniasis: an emerging infection among deployed US military and civilian workers. Clin Infect Dis. 2004;39:1674-1680.
249. Piscopo TV, Mallia AC. Leishmaniasis. Postgrad Med J. 2006;82:649-657.
250. Guerin PJ, Olliaro P, Sundar S, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002;2:494-501.
251. Di Lella F, Vincenti V, Zennaro D, et al. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa. Int J Oral Maxillofac Surg. 2006;35:870-872.
252. Aliaga L, Cobo F, Mediavilla JD, et al. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients. Medicine (Baltimore). 2003;82:147-158.
253. Delbrouck C, Choufani G, Nagy N, et al. Systemic leishmaniasis involving the nose. Acta Otorhinolaryngol Belg. 2003;57:83-85.
254. Shareef MM, Trotter MI, Cullen RJ. Leishmaniasis of the nasal cavity: a case report. J Laryngol Owl. 2005;119:1015-1017.
255. Lambertucci JR, Coulaud R, Silva LC. Mucosal leishmaniasis. Rev Soc Bras Med Trop. 2003;36:307-308.
256. Guerreiro JB, Cruz AA, Barral A, et al. Mucosal leishmaniasis: quantitative nasal cytology as a marker of disease activity and indicator of healing. Ann Otol Rhinol Laryngol. 2000;109:89-94.
257. van Eys GJ, Schoone GJ, Ligthart GS, et al. Detection of Leishmania parasites by DNA in situ hybridization with non-radioactive probes. Parasitol Res. 1987;73:199-202.
258. Frenkel JK. Toxoplasmosis. In: Connor DH, Chandler FW, Schwartz DA, et al, ed. Pathology of Infectious Diseases. Stamford, CT: Appleton and Lange; 1997:1261-1278.
259. McCabe RE, Brooks RG, Dorfman RF, et al. Clinical spectmm in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis. 1987;9:754-774.
260. Viguer JM, Jimenez-Heffernan JA, Lopez-Ferrer P, et al. Fine needle aspiration of toxoplasmic (Piringer-Kuchinka) lymphadenitis: a cytohistologic correlation study. Acta Cytol. 2005;49:139-143.
261. Barbara A, Shehadeh-Masha'our R, Sartani G, et al. Reactivation of ocular toxoplasmosis after LASIK. J Refract Surg. 2005;21:759-761.
262. Laibe S, Ranque S, Curtillet C, et al. Timely diagnosis of disseminated toxoplasmosis by sputum examination. J Clin Microbiol. 2006;44:646-648.
263. Cermakova Z, Ryskova O, Pliskova L. Polymerase chain reaction for detection of Toxoplasma gondii in human biological samples. Folia Microbiol (Praha). 2005;50:341-344.
264. 264- Switaj K, Master A, Skrzypczak M, et al. Recent trends in molecular diagnostics for Toxoplasma gondii infections. Clin Microbiol Infect. 2005;11:170-176.
265. Montone KT. In situ hybridization for ribosomal RNA sequences: a rapid, sensitive method for diagnosis of infectious pathogens in anatomic pathology substrates. Acta Histochem Cytochem. 1994;27:601-606.
266. Rosai J. The nature of myospherulosis of the upper respiratory tract. Am J Clin Pathol. 1978;69:475-481.
267. Suresh E. Diagnostic approach to patients with suspected vasculitis. Postgrad Med J. 2006;82:483-488.
268. Mandell BF, Calabrese LH. Infections and systemic vasculitis. Curr Opin Rheumatol. 1998;10:51-57.